Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
Management
Medical & Scientific Advisory Board
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
NeuCA15-3 Test
NeuCA125 Test
EXO-Ovarian Cancer Test
Exosome Therapeutics
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
AGM
Heading &
Sub-heading can be edited through HQI
Investors
>
AGM
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
AGM
Content coming soon.
Access AGM Presentation
Notice of Annual General Meeting
The Annual General Meeting of the Company was held at the offices of Grant Thornton, Level 22, Collins Square, Tower 5/727 Collins Street, Melbourne, Victoria on Thursday, 28 November 2024 at 10.00am (AEDT).
Annual Report
View Report
CEO Presentation
View Presentation
Notice of Annual General Meeting
View Report
Annual General Meeting Outline
Resolution 1: Adoption of Remuneration Report
Resolution 2a: Re-election of Robert (Max) Johnston as Non-executive Director
2b Re-election of Philip Powell as Non-executive Director
2c Election of Mary Harney as Non-executive Director
3 Approval of 10% Placement Capacity
4a Issue of Options to Mr Robert (Max) Johnston
4b Issue of Options to Mr Philip Powell
4c Issue of Options to Dr Geoff Cumming
4d Issue of Options to Ms Mary Harney
AGM Announcements
Read More
Email Alerts
For Investors
Contact Us
